Dopheide, Joern F.; Rubrech, Jennifer; Trumpp, Amelie et al.
Leukocyte-platelet aggregates-a phenotypic characterization of different stages of peripheral arterial diseasePLATELETS. Bd. 27. H. 7. 2016 S. 658-667
Gomez-Quiroz, Luis E.; Seo, Daekwan; Lee, Yun-Han et al.
Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stressTOXICOLOGY. Bd. 361. 2016 S. 39-48
Hausen, Zur G.; Waldmann, O.; Woerns, M. -A et al.
Nab-paclitaxel/Gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values - data from the German QoliXane pancreatic cancer registryONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 259-259
zur Hausen, G.; Waidmann, O.; Woerns, M. A. et al.
Nab-paclitaxel/gemcitabine first line therapy in patients with metastatic pancreatic carcinoma and high-bilirubin values Data from the German QoliXane pancreatic cancer registryANNALS OF ONCOLOGY. Bd. 27. 2016
Matter, Matthias S.; Marquardt, Jens U.; Andersen, Jesper B. et al.
Oncogenic Driver Genes and the Inflammatory Microenvironment Dictate Liver Tumor PhenotypeHEPATOLOGY. Bd. 63. H. 6. 2016 S. 1888-1899
Grimm, Daniel; Lieb, Jonas; Weyer, Veronika et al.
Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatmentBMC CANCER. Bd. 16. 2016
Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.
Past, present and future of immunology in MainzCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6
Faetkenheuer, G.; Jessen, H.; Stoehr, A. et al.
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxisHIV MEDICINE. Bd. 17. H. 6. 2016 S. 453-459
Galle, Peter R.
Professor Dr. med. Bertram Wiedenmann - Presentation of the Congress President of the German Society of Gastroenterology, Digestive and Metabolic DiseasesZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 54. H. 8. 2016 S. 731-732
Knopl, Viola; Vermehren, Johannes; Petersen, Joerg et al.
Profile of viral, biochemical and non-invasive fibrosis markers in a cohort of inactive European hepatitis B (HBV) carriers: 3 years follow-up of a prospective longitudinal study (ALBATROS Study)HEPATOLOGY. Bd. 63. H. 1 SUPP. 2016 S. 905A-906A